{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-016486","form_type":"8-K","ticker":"BIAF","cik":"0001712762","company_name":"bioAffinity Technologies, Inc.","filed_at":"2026-04-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.792867+00:00","generated_at":"2026-05-15T06:23:58.871950+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"CyPath® Lung case study shows test helped defer biopsy for high-risk patient with 30mm nodule","bullets":["70-year-old female, 50 pack-year smoking history, 30mm lung nodule with high cancer risk by imaging and models.","CyPath® Lung returned negative result ('Unlikely Malignancy'); follow-up CT showed nodule had completely resolved.","Treating pulmonologist credited CyPath® Lung for prompting additional imaging before scheduled biopsy.","CyPath® Lung demonstrated 92% sensitivity, 87% specificity, and 88% accuracy in detecting lung cancer in small nodules in clinical trial.","Case illustrates potential to avoid risky, unnecessary procedures in patients with comorbidities like emphysema."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-016486","json":"https://secwatch.observer/filing/0001493152-26-016486.json","markdown":"https://secwatch.observer/filing/0001493152-26-016486.md","text":"https://secwatch.observer/filing/0001493152-26-016486.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226016486/0001493152-26-016486-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226016486/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T06:23:58.871950+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}